Omnipaque Injection, Solution
NDC Package 0407-1412-10

11-digit billing NDC: 00407141210 · Billing unit: ML · 100 ML per package

Package Information

Omnipaque (iohexol) injection is oMNIPAQUE injection 300 mg iodine/mL and OMNIPAQUE injection 350 mg iodine/mL in 500 mL bottles may be used as an Imaging Bulk Package (IBP) for intravenous use [see Dosage and Administration (2.4, 2.8)]. This formulation utilizes a injection, solution delivery system. Marketed by Ge Healthcare Inc., this product is identified by NDC 0407-1412 and is authorized under FDA application NDA018956.

Identification & Billing

NDC Package Code
0407-1412-10
Package Description
10 VIAL, GLASS in 1 BOX / 10 mL in 1 VIAL, GLASS
Product Code
11-Digit Billing Format
00407141210
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
100 ML

Clinical Specifications

Proprietary Name
Omnipaque
Non-Proprietary Name
Iohexol
Substance Name
Iohexol
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Intra-articular - Administration within a joint.
  • Intrathecal - Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.
  • Intravascular - Administration within a vessel or vessels.
  • Intravenous - Administration within or into a vein or veins.
  • Oral - Administration to or by way of the mouth.
  • Rectal - Administration to the rectum.
Active Ingredient(s)
Usage Information
OMNIPAQUE injection 300 mg iodine/mL and OMNIPAQUE injection 350 mg iodine/mL in 500 mL bottles may be used as an Imaging Bulk Package (IBP) for intravenous use [see Dosage and Administration (2.4, 2.8)]. When used as an IBP, check the appropriate box on the container label to indicate that the selected container is to be utilized as an Imaging Bulk Package. This container is for use only with an automated contrast injection system, contrast management system, or contrast media transfer set approved or cleared for use with this contrast agent in this IBP. See device labeling for information on devices indicated for use with this IBP and techniques to help assure safe use.Use the OMNIPAQUE IBP and 0.9% Sodium Chloride Injection USP in a room designated for radiological procedures that involve administration of a contrast agent.Using aseptic technique, penetrate the container closure only one time with a suitable sterile component of the automated contrast injection system, contrast management system, or contrast media transfer set cleared for use with the OMNIPAQUE IBP.If 0.9% Sodium Chloride Injection USP is used with the OMNIPAQUE IBP, prepare the 0.9% Sodium Chloride Injection USP sterile port in accordance with the dosage and administration section of its approved prescribing information and affix the saline tag provided with the OMNIPAQUE IBP on the 0.9% Sodium Chloride Injection USP container.Once the OMNIPAQUE IBP and 0.9% Sodium Chloride Injection containers are punctured, do not remove them from the work area during the entire period of use. Maintain the OMNIPAQUE IBP in an inverted position such that container contents are in continuous contact with the dispensing set.After the container closure is punctured, if the integrity of the OMNIPAQUE IBP, the 0.9% Sodium Chloride Injection, and the delivery system cannot be assured through direct continuous supervision, discard the IBP, 0.9% Sodium Chloride Injection USP, and all associated disposables for the contrast media transfer set.A maximum time from initial puncture is 8 hours. Discard any unused portion.

Regulatory & Marketing

Labeler Name
Ge Healthcare Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA018956
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-26-1985
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

Source: ASP
Locm 200-299mg/ml iodine,1ml
HCPCS Dosage 1 ML
Units / Pkg 100

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0407-1412). Click a package code to view its specific billing and regulatory data.

10 VIAL, GLASS in 1 BOX / 20 mL in 1 VIAL, GLASS
10 BOTTLE, PLASTIC in 1 BOX / 150 mL in 1 BOTTLE, PLASTIC
10 BOTTLE, PLASTIC in 1 BOX / 200 mL in 1 BOTTLE, PLASTIC
10 BOTTLE, PLASTIC in 1 BOX / 50 mL in 1 BOTTLE, PLASTIC
10 BOTTLE, PLASTIC in 1 BOX / 50 mL in 1 BOTTLE, PLASTIC
10 BOTTLE, PLASTIC in 1 BOX / 100 mL in 1 BOTTLE, PLASTIC
10 BOTTLE, PLASTIC in 1 BOX / 150 mL in 1 BOTTLE, PLASTIC
10 BOTTLE, PLASTIC in 1 BOX / 200 mL in 1 BOTTLE, PLASTIC
10 BOTTLE, PLASTIC in 1 BOX / 50 mL in 1 BOTTLE, PLASTIC
10 BOTTLE, PLASTIC in 1 BOX / 100 mL in 1 BOTTLE, PLASTIC
10 BOTTLE, PLASTIC in 1 BOX / 150 mL in 1 BOTTLE, PLASTIC
10 BOTTLE, GLASS in 1 BOX / 150 mL in 1 BOTTLE, GLASS
10 VIAL, GLASS in 1 BOX / 50 mL in 1 VIAL, GLASS
10 BOTTLE, GLASS in 1 BOX / 100 mL in 1 BOTTLE, GLASS
10 BOTTLE in 1 BOX / 100 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0407-1412-10 identifies a specific commercial package of 10 vial, glass in 1 box / 10 ml in 1 vial, glass of Omnipaque, a human prescription drug labeled by Ge Healthcare Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 100 billable units per package. This injection, solution is formulated for intra-articular; intrathecal; intravascular; intravenous; oral; rectal use and contains iohexol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ge Healthcare Inc. on December 26, 1985. The current certification is valid through December 31, 2027.

How is this Ge Healthcare Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00407141210. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0407-1412-10
11-Digit CMS (5-4-2)
00407-1412-10

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.